About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Mylan Arbitration Hearing Concluded
November 9, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Entitlement Offer Raises Over AUD3M
Next Post
Phosphagenics Provides Update on TPM Propofol Development Program
Related Posts
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
January 31, 2017
CBD soft-gel product design complete
May 21, 2021
May 21, 2021
Retirement of Non-Executive Director
May 28, 2018